Showing results (101-110 of 234) with videos related to

Sort By:
Pageof 24
Blood|July 23, 2005
JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemiaJaroslav Jelinek, Yasuhiro Oki, Vazganush Gharibyan, et al.
Cancer|November 30, 2006
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphomaYasuhiro Oki, Peter McLaughlin, Luis E Fayad, et al.
British Journal of Haematology|March 31, 2015
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approachYasuhiro Oki, Sattva S Neelapu, Michelle Fanale, et al.
Leukemia & Lymphoma|April 27, 2018
Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failureEthan B Ludmir, Sarah A Milgrom, Chelsea C Pinnix, et al.
Advances in Radiation Oncology|November 9, 2017
Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphomaGrace L Smith, Madeleine Duvic, Zeinab Abou Yehia, et al.
Blood Advances|November 7, 2025
Clinical Trial Success Rate in Lymphoma: Fate of Trials and Agents from 2000 to 2019Zhiping Luo, Meng Li, Brian Primeaux, et al.
European Journal of Haematology|January 1, 2017
Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCHBeenu Thakral, L Jeffrey Medeiros, Parth Desai, et al.
American Journal of Hematology|July 24, 2018
Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 studyIan W Flinn, Manish Patel, Yasuhiro Oki, et al.
British Journal of Haematology|May 9, 2015
Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in JapanDai Chihara, Naoko Asano, Ken Ohmachi, et al.
Bone Marrow Transplantation|August 12, 2020
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemiaAyumi Fujimoto, Fumihiro Ishida, Koji Izutsu, et al.
Pageof 24